Evidence-based personal applications of medical computing models in risk factors of cardiovascular disease for the middle-aged and elderly

2018 ◽  
Vol 22 (5-6) ◽  
pp. 921-936 ◽  
Author(s):  
Ching-Hsue Cheng ◽  
You-Shyang Chen ◽  
Arun Kumar Sangaiah ◽  
Yin-Hsiu Su
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Evidence Based ◽  
Middle Aged ◽  
Medical Computing ◽  
Computing Models

scholarly journals Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease

Aging Cell ◽  
2007 ◽  
Vol 6 (5) ◽  
pp. 639-647 ◽  
Author(s):  
Sofie Bekaert ◽  
Tim De Meyer ◽  
Ernst R. Rietzschel ◽  
Marc L. De Buyzere ◽  
Dirk De Bacquer ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Telomere Length ◽  
Middle Aged ◽  
Aged Population

The effect of exercise and diet on mental health and quality of life in middle-aged individuals with elevated risk factors for cardiovascular disease

1999 ◽  
Vol 17 (5) ◽  
pp. 369-377 ◽  
Author(s):  
MARIT SORENSEN ◽  
SIGMUND ANDERSSEN ◽  
INGVAR HJERMAN ◽  
INGAR HOLME ◽  
HOLGER URSIN
Keyword(s):  
Quality Of Life ◽  
Mental Health ◽  
Risk Factors ◽  
Cardiovascular Disease ◽  
Elevated Risk ◽  
Middle Aged

Gender differences in cardiovascular disease prevention

2008 ◽  
Vol 14 (1) ◽  
pp. 13-17 ◽  
Author(s):  
Graham Jackson
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Health Care Professionals ◽  
Coronary Event ◽  
The Other ◽  
Evidence Based ◽  
Modifiable Risk Factors ◽  
Psychosocial Issues ◽  
Men And Women ◽  
Lack Of Exercise

Risk factors are generally shared between men and women with the major differences being hormonal. Nine modifiable risk factors account for over 90% of the risk of a coronary event in men and women – smoking, hypertension, hyperlipidaemia, diabetes, abdominal obesity, lack of exercise, alcohol excess, reduced intake of fruit and vegetables, and psychosocial issues. Approximately half the decline in deaths from coronary heart disease (CHD), between 1980 and 2000, can be attributed to a reduction in the major risk factors and the other half to the use of evidence-based management. As educational efforts to increase awareness of cardiovascular disease (not cancer) to be the leading cause of death and disability in women are also associated with preventative action, it is important that health-care professionals educate themselves about CHD in women and communicate with women themselves, so that women can come forward for advice and evaluation.

Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach

2017 ◽  
Vol 8 (6) ◽  
pp. 2076-2088 ◽  
Author(s):  
Arrigo F. G. Cicero ◽  
Federica Fogacci ◽  
Alessandro Colletti
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Cardiovascular Disease Risk Factors ◽  
Cardiometabolic Disease ◽  
Evidence Based ◽  
Cardiometabolic Disease Risk

Nutraceuticals active on the main cardiovascular disease risk factors.

Relationship of Blood Pressure and Cardiovascular Disease Risk Factors in Normotensive Middle-Aged Men

Medicine ◽  
2011 ◽  
Vol 90 (5) ◽  
pp. 344-349 ◽  
Author(s):  
Dee Pei ◽  
Yen-Lin Chen ◽  
Sai-Hung Tang ◽  
Chung-Ze Wu ◽  
Jiunn-Diann Lin ◽  
...  
Keyword(s):  
Risk Factors ◽  
Blood Pressure ◽  
Cardiovascular Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Cardiovascular Disease Risk Factors ◽  
Middle Aged ◽  
Relationship Of

scholarly journals Antioxidant Effects of Salidroside in the Cardiovascular System

2020 ◽  
Vol 2020 ◽  
pp. 1-9
Author(s):  
Siyu Sun ◽  
Qinhui Tuo ◽  
Dongxu Li ◽  
Xiulong Wang ◽  
Xuefang Li ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Disease ◽  
Cardiovascular Diseases ◽  
Health Risks ◽  
Therapeutic Strategies ◽  
Therapeutic Effects ◽  
Evidence Based ◽  
Human Health Risks ◽  
Bioactive Component ◽  
Antioxidant Effects

Cardiovascular disease is one of the main human health risks, and the incidence is increasing. Salidroside is an important bioactive component of Rhodiola rosea L., which is used to treat Alzheimer’s disease, tumor, depression, and other diseases. Recent studies have shown that salidroside has therapeutic effects, to some degree, in cardiovascular diseases via an antioxidative mechanism. However, evidence-based clinical data supporting the effectiveness of salidroside in the treatment of cardiovascular diseases are limited. In this review, we discuss the effects of salidroside on cardiovascular risk factors and cardiovascular diseases and highlight potential antioxidant therapeutic strategies.

Sign in / Sign up

Export Citation Format

Share Document